Pharmhouse Corp
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +73,166.2% | -35.9% | -3.9% | -20.4% | -3.3% | +34,249.3% | -0.5% | -40.7% | -96.9% | +483.7% | +8,348.1% | |
| – | +40,750.3% | -67.5% | +0.0% | -64.9% | -13.3% | +262,674.9% | -0.6% | -45.7% | -96.2% | +200.0% | +2,679.6% | |
| – | +56,883.4% | -74.2% | +0.0% | -93.1% | -96.9% | +300,554.5% | – | – | – | +200.0% | -38.2% | |
| – | +56,883.4% | -74.2% | +0.0% | -93.1% | -96.9% | +300,554.5% | – | – | – | +200.0% | -38.2% | |
| – | -9.8% | -18.7% | +0.0% | +0.0% | +0.0% | -97.3% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +2,090.6% | |
| – | +76,788.7% | +18.1% | +2.6% | -10.0% | +1.9% | +596.0% | -52.7% | +207.2% | -9.1% | +378.7% | +368.4% | |
| – | +76,788.7% | +18.1% | +2.6% | -10.0% | +1.9% | +596.0% | -52.7% | +207.2% | -9.1% | +378.7% | +358.2% | |
| – | +99,317.5% | +2,264.3% | -95.8% | +0.0% | +70.8% | – | – | – | +218.2% | +306.8% | +231.2% | |
| – | – | – | – | – | – | – | -52.7% | +120.5% | – | – | +29,926.3% | |
| – | – | – | – | – | – | – | – | – | – | – | +4.5% | |
| – | +56,616.7% | -370.3% | – | – | – | – | +1.7% | -45.6% | -106.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +0.3% | +0.0% | -0.7% | +0.7% | +255.1% | +0.4% | +0.0% | +222.2% | +180.6% | +80.3% |
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.